Preveta, a trailblazer in AI-powered healthtech, announced a new collaboration with IntrinsiQ Specialty Solutions, part of Cencora, a global healthcare company. Through IntrinsiQ’s Trusted Vendor Pr...
LOS ANGELES: Preveta, a trailblazer in AI-powered healthtech, announced a new collaboration with IntrinsiQ Specialty Solutions, part of Cencora, a global healthcare company. Through IntrinsiQ’s Trusted Vendor Program, which is comprised of a portfolio of cutting-edge operational and clinical care solutions, this effort aims to equip specialty care practices with advanced clinical analytics and care navigation technology.
Integrating Preveta's platform with IntrinsiQ’s network of specialty physician customers enables optimization of specialty care delivery at scale. Preveta uniquely bridges the gap between clinical data and treatment pathways through sophisticated data science, analyzing millions of data points to identify patients needing intervention — transforming how providers monitor and manage their patient populations.
“Despite advances in treatments, fragmented care navigation and clinical data mean too many patients miss life-saving opportunities. The American Cancer Society reports that one in four cancer deaths could have been prevented through better navigation and more effective use of clinical data,” said Victor Lee, co-founder and CEO of Preveta. "Our mission is to ensure patients don’t fall through the cracks in their treatment journey.”
In an era where treatment decisions grow more complex and time-sensitive, oncology and specialty care providers need sophisticated tools to ensure no patient misses a crucial intervention. Preveta brings precision to care delivery, automatically flagging disease progression signals, overdue follow-ups, and clinical trial opportunities, enabling practices to take immediate action when it matters most.
"As our customers navigate new challenges and pressures, we're focused on creating new solutions and strategic relationships that enable us to deliver enhanced support tailored to their needs,” said Charley Deckers, VP of Business Development & Specialty Pharmacy Solutions, Cencora. “This collaboration with Preveta reflects that commitment, as their capabilities in clinical analytics and care navigation are unmatched. Their mastery of clinical pathways and data science helps doctors prevent patients from falling through the cracks, which is in direct alignment with our mission to help create healthier futures for all.”
To schedule a meeting with our executive team or access our investor presentation, please contact our IR department at contact@preveta.com.
About Preveta
Preveta's AI-powered platform transforms complex clinical data into immediate, actionable insights that ensure every cancer patient receives the right care at the right time.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Today, Securonix, a five-time Leader in the Gartner® Magic Quadrant™ for Security Information and Event Management (SIEM), announced the acquisition of…
Anjuna, a leader in Confidential Computing and AI Data Fusion Clean Rooms, today announced the addition of a new top five global bank to its growing roster…
PubNub, the leader in real-time interactive apps, unveiled the next evolution of its platform. It introduces AI-native development, real-time decision…
Work AI leader Glean today announced it raised $150 million in Series F financing, bringing its valuation to $7.2 billion. The round was led by Wellington…